Skip to main content
Equibles
DRIO logo

DRIO · DarioHealth Corp.

Track DRIO — free

Use DRIO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DRIO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.59 +0.26 (+3.48%) At close · Aug 14
Going-concern doubt — cleared Aug 11, 2026

The latest filing no longer states the doubt (first flagged May 13, 2026).

View the 10-Q filed Aug 11, 2026
Market Cap
$74.33M
Shares
9.80M

DarioHealth Corp. Earnings Call Transcripts

Every quarterly earnings call for DarioHealth Corp. (DRIO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲17.5% $6.18M −$18.03M '22 Q2 22-08-15 ▲17.3% $6.61M −$15.63M '22 Q3 22-09-30 ▲13% $6.81M −$12.62M '22 Q4 23-02-06 ▼12.3% $7.07M −$12.82M '23 Q1 23-03-31 ▼0.5% $6.15M −$16.59M '23 Q2 23-07-24 ▼46.7% $3.52M −$15.73M '23 Q3 23-09-30 ▼46.9% $3.62M −$14.29M '23 Q4 23-12-31 ▼18.5% $5.76M −$7.17M '24 Q1 24-03-31 ▲1.7% $6.25M −$13.61M '24 Q2 24-06-30 ▲111% $7.42M −$12.33M '24 Q3 24-09-30 ▲110.3% $7.60M −$9.63M '24 Q4 24-12-31 ▲17.3% $6.75M −$9.23M '25 Q1 25-03-31 ▼14.2% $5.37M −$12.99M '25 Q2 25-06-30 ▼32.5% $5.01M −$10.47M '25 Q3 25-09-30 ▼31.2% $5.23M −$9.03M '25 Q4 25-12-31 LATEST ▼17.3% $5.58M −$8.25M '26 Q1 26-03-31
Earnings call
FY26 · Q1
2026-03-31
DarioHealth Corp. Q1 FY2026 Earnings Call
Confident tone Channel partnerships and covered lives expansion Evolution into care delivery / outcomes-based models Pipeline and health system / health plan opportunities
Revenue
$5.58M
▼ 17.3% YoY
Diluted EPS
$1.25
▼ 56.4% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
DarioHealth Corp. Q4 FY2025 Earnings Call
Revenue
$5.23M*
▼ 31.2% YoY
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
DarioHealth Corp. Q3 FY2025 Earnings Call
Confident tone Channel partners and covered lives New client wins and pipeline Revenue growth and multi-condition platform
Revenue
$5.01M
▼ 32.5% YoY
Diluted EPS
$2.96
▼ 39.7% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
DarioHealth Corp. Q2 FY2025 Earnings Call
Positive tone Multi-condition platform and GLP-1 strategy Claims-based billing expansion Margin improvement and cost reduction
Revenue
$5.37M
▼ 14.2% YoY
Diluted EPS
$3.54
▲ 121.2% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
DarioHealth Corp. Q1 FY2025 Earnings Call
Positive tone Twill Acquisition Integration AI Strategy Pharma Partnerships
Revenue
$6.75M
▲ 17.3% YoY
Diluted EPS
$2.87
▼ 28.2% YoY
Gross margin
57.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
DarioHealth Corp. Q4 FY2024 Earnings Call
Confident tone Multi-condition / whole-person care GLP-1 companion solutions Revenue and gross margin performance
Revenue
$7.60M*
▲ 110.3% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
DarioHealth Corp. Q3 FY2024 Earnings Call
Confident tone Revenue growth and B2B2C channel Operating expense reduction and path to profitability Twill integration and restructuring
Revenue
$7.42M
▲ 111% YoY
Diluted EPS
$4.91
▼ 49.9% YoY
Gross margin
52.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
DarioHealth Corp. Q2 FY2024 Earnings Call
Positive tone B2B2C channel growth Pharma channel transition and price concession Twill acquisition integration and cross-selling
Revenue
$6.25M
▲ 1.7% YoY
Diluted EPS
$1.60
▼ 86.2% YoY
Gross margin
44.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
DarioHealth Corp. Q1 FY2024 Earnings Call
Confident tone Twill acquisition synergies Major customer relationships B2B2C recurring revenue channel
Revenue
$5.76M
▼ 18.5% YoY
Diluted EPS
$4.00
▼ 55.6% YoY
Gross margin
42.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
DarioHealth Corp. Q4 FY2023 Earnings Call
Revenue
$3.62M*
▼ 46.9% YoY
Gross margin
3.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
DarioHealth Corp. Q3 FY2023 Earnings Call
Revenue
$3.52M
▼ 46.7% YoY
Diluted EPS
$9.80
▼ 23.4% YoY
Gross margin
17.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-24
DarioHealth Corp. Q2 FY2023 Earnings Call
Revenue
$6.15M
▼ 0.5% YoY
Diluted EPS
$11.60
▼ 21.6% YoY
Gross margin
33.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
DarioHealth Corp. Q1 FY2023 Earnings Call
Revenue
$7.07M
▼ 12.3% YoY
Diluted EPS
$9.00
▼ 39.2% YoY
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-06
DarioHealth Corp. Q4 FY2022 Earnings Call
Revenue
$6.81M*
▲ 13% YoY
Gross margin
40.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
DarioHealth Corp. Q3 FY2022 Earnings Call
Revenue
$6.61M
▲ 17.3% YoY
Diluted EPS
$12.80
▼ 45.8% YoY
Gross margin
27.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
DarioHealth Corp. Q2 FY2022 Earnings Call
Revenue
$6.18M
▲ 17.5% YoY
Diluted EPS
$14.80
▼ 25.3% YoY
Gross margin
18.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
DarioHealth Corp. Q1 FY2022 Earnings Call
Revenue
$8.06M
▲ 124.2% YoY
Diluted EPS
$14.80
▼ 19.6% YoY
Gross margin
49.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-19
DarioHealth Corp. Q4 FY2021 Earnings Call
Revenue
$6.03M*
▲ 189.8% YoY
Gross margin
9.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
DarioHealth Corp. Q3 FY2021 Earnings Call
Revenue
$5.63M
▲ 175.7% YoY
Diluted EPS
$23.60
Gross margin
14.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
DarioHealth Corp. Q2 FY2021 Earnings Call
Revenue
$5.26M
▲ 194.4% YoY
Diluted EPS
$19.80
Gross margin
28.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
DarioHealth Corp. Q1 FY2021 Earnings Call
Revenue
$3.60M
▲ 115.7% YoY
Diluted EPS
$18.40
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
DarioHealth Corp. Q4 FY2020 Earnings Call
Revenue
$2.08M*
▲ 15.7% YoY
Gross margin
26.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
DarioHealth Corp. Q3 FY2020 Earnings Call
Revenue
$2.04M
▲ 9.3% YoY
Diluted EPS
$-14.20
Gross margin
26.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
DarioHealth Corp. Q2 FY2020 Earnings Call
Revenue
$1.79M
▲ 8.2% YoY
Diluted EPS
$-13.60
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
DarioHealth Corp. Q1 FY2020 Earnings Call
Revenue
$1.67M
▼ 25.6% YoY
Gross margin
46.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1533998 CUSIP 23725P308 13F (30d) 21 filings 21 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)